CTCAE grade 3/4 infections occurred in 65 (9.7%) of 670 cycles in 2017–2019 and in 22 (9.2%) of 239 cycles during the COVID-19 protection period, while there was a strong trend towards fewer low-grade infections of CTCAE grade 1/2 during the COVID-19 lockdown period (8 cycles, 3.3%) compared with the 2017–2019 reference period (66 cycles, 9.9%) (Table 3 ).
← all excerpts
Impact of the first COVID-19 lockdown in Germany on the rate of acute infections during intensive chemotherapy for Hodgkin lymphoma.
1
—
—